Smiths Group (SMIN) Earns “Overweight” Rating from JPMorgan Chase & Co.

JPMorgan Chase & Co. reaffirmed their overweight rating on shares of Smiths Group (LON:SMIN) in a research note issued to investors on Monday. JPMorgan Chase & Co. currently has a GBX 1,800 ($24.41) target price on the stock.

Several other analysts have also recently issued reports on the company. Numis Securities upgraded Smiths Group to an add rating and set a GBX 1,725 ($23.39) target price for the company in a research report on Friday, January 12th. Credit Suisse Group reiterated an outperform rating and set a GBX 1,730 ($23.46) target price on shares of Smiths Group in a research report on Friday, December 8th. Deutsche Bank reiterated a buy rating and set a GBX 1,750 ($23.73) target price on shares of Smiths Group in a research report on Monday, December 4th. reiterated a buy rating and set a GBX 1,900 ($25.77) target price on shares of Smiths Group in a research report on Friday, September 29th. Finally, Goldman Sachs Group reiterated a buy rating and set a GBX 1,850 ($25.09) target price on shares of Smiths Group in a research report on Friday, September 22nd. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The stock has a consensus rating of Buy and an average price target of GBX 1,770 ($24.00).

Smiths Group (LON:SMIN) traded up GBX 3 ($0.04) during trading hours on Monday, hitting GBX 1,673.50 ($22.69). The company had a trading volume of 1,330,554 shares, compared to its average volume of 1,150,000. Smiths Group has a 12-month low of GBX 1,442 ($19.56) and a 12-month high of GBX 1,697 ($23.01). The stock has a market capitalization of $6,620.00 and a PE ratio of 1,178.52.

In other news, insider George Buckley purchased 1,111 shares of the company’s stock in a transaction that occurred on Wednesday, November 1st. The stock was bought at an average cost of GBX 1,577 ($21.39) per share, with a total value of £17,520.47 ($23,759.79).

ILLEGAL ACTIVITY WARNING: “Smiths Group (SMIN) Earns “Overweight” Rating from JPMorgan Chase & Co.” was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://ledgergazette.com/2018/01/19/smiths-group-smin-earns-overweight-rating-from-jpmorgan-chase-co.html.

About Smiths Group

Smiths Group plc is a technology company. The Company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. The John Crane division offers mechanical seals, seal support systems, engineered bearings and power transmission couplings, among others. The Smiths Medical division offers infusion systems, vascular access (including safety needles), patient airway and temperature management equipment, and specialty devices in areas of in vitro fertilization, diagnostics and emergency patient transport.

Analyst Recommendations for Smiths Group (LON:SMIN)

Receive News & Ratings for Smiths Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smiths Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply